Guidelines for clinical trial design for evaluation of MMP inhibitors.
Greenwald
R A
RA
Division of Rheumatology, Long Island Jewish Medical Center, New Hyde Park, New York 11042.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000592:standards*; D004195:Disease Models, Animal; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D008666:Metalloendopeptidases